What are people's thoughts on last night’s budget for MVP?
My understanding is that new bio-med patents that are lodged from 1/7/22 will be eligible for a significant tax discount. Is this a tailwind for MVP looking forward? Does it also skew potentially application timings for such patents? Curious what people think the implications might be.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.010(1.69%) |
Mkt cap ! $67.59M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 60.0¢ | 58.5¢ | $36.88K | 62.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4825 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.45pm 15/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |